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INTRODUCTION
Nitric oxide (NO) is an unstable, short-lived, and potential
toxic radical, produced by the oxidation of L-arginine by nitric
oxide synthase (NOS) (1, 2). NO exhibits a rich biochemistry
and a high reactivity and plays an important role as intercellular
messenger in diverse physiologic processes, such as regulation
of blood flow, neurotransmitter, and platelet aggregation (3).
NOS is divided into two major groups, constitutive NOS
(cNOS) and inducible NOS (iNOS). cNOS are calcium-depen-
dent and two isoforms are present, the brain form (bNOS) and
the endothelial form (eNOS) (4, 5). In contrast, iNOS is a
calcium-independent enzyme, and releases far greater amounts
of NO and exerts cytotoxic and cytostatic effects not only
against invading pathogens, but also against healthy cells
(6-8). iNOS is induced in a number of cell types, such as
fibroblasts, macrophages, and epithelium of the iris-ciliary
body, especially after stimulation by cytokines, such as inter-
leukin-1 (IL-1 ), tumor necrosis factor- (TNF- ), and
lipopolysaccharides (LPS) (9-12).
The effects of cell injury caused by NO have been postu-
lated, both through direct or indirect chemical interactions
with reactive oxygen species (ROS), such as superoxide to form
other oxygen species that are potentially much toxic. Per-
oxynitrite is one of them, an extremely potent oxidant, which
can lead to substantial cellular damage through lipid per-
oxidation and tyrosine nitration of protein (13, 14).
In the eye, it has been known that NO plays a significant
role in the viability of cells in ocular surface tissue, but the role
of NO in ocular surface diseases is still under investigation. 
To assess the role of NO in ocular surface, we have firstly
performed in vivo studies regarding the main source of
NOS, the concentration of NO and NO-mediated toxicity
in ocular surface diseases. Based on these in vivo experiments,
finally, we have studied the critical NO level and its influence
on cell survival with various concentrations of exogenous
NO donor administered in corneal fibroblast culture system
with or without serum.
MATERIALS AND METHODS
Nitric oxide assay, morphometric study, and western
blotting (in vivo study)
All experiments were carried out in accordance with the
ARVO statement for the Use of Animals in Ophthalmic and
Vision Research. Adult white rabbits (n=30), weighing 2-2.5
kg, were used in this study. The rabbits were divided into five
groups. Group I was normal control. In group II, excimer laser
ablation was performed using Apex-plus (Summit Technol-
ogy, Waltham, MA, U.S.A.) (15). In group III, the experi-
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The Role of Nitric Oxide in Ocular Surface Cells
The role of nitric oxide (NO) in the ocular surface remains unknown. We investi-
gated the conditions leading to an increase of NO generation in tear and the main
sources of NO in ocular surface tissue. We evaluated the dual action (cell survival
or cell death) of NO depending on its amount. We measured the concentration of
nitrite plus nitrate in the tears of ocular surface diseases and examined the main
source of nitric oxide synthase (NOS). When cultured human corneal fibroblast
were treated with NO producing donor with or without serum, the viabilities of cells
was studied. We found that the main sources of NO in ocular surface tissue were
corneal epithelium, fibroblast, endothelium, and inflammatory cells. Three forms
of NOS (eNOS, bNOS, and iNOS) were expressed in experimentally induced inflam-
mation. In the fibroblast culture system, the NO donor (SNAP, S-nitroso-N-acetyl-D,
L-penicillamine) prevented the death of corneal fibroblast cells caused by serum
deprivation in a dose dependent manner up to 500  M SNAP, but a higher dose
decreased cell viability. This study suggested that NO might act as a double-
edged sword in ocular surface diseases depending on the degree of inflammation
related with NO concentration.
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mental allergic conjunctivitis was developed by topical appli-
cation of codeine phosphate (mast cell activator) (16). Group
IV was provoked by intravitreal injection of lipopolysaccha-
ride (LPS) (10 ng/eye) (17). Group V was provoked by sub-
conjunctival injection of NO donor S-nitroso-N-acetyl-D,
L-penicillamine (SNAP) (50  M). Each group consisted of
6 rabbits. To investigate the effect of NOS inhibitors, each
group was divided into two subgroups, and N-nitro-L-argi-
nine methyl ester (L-NAME), 200  g/eye and placebo Bal-
anced salt solution (BSS) were injected subconjunctivally at
60 min before provocation as pretreatment.
The tear and aqueous humor samples of rabbits were col-
lected using porous transorb polyester rod (American Filtrona
Co. U.S.A.) and 30-gauge needle syringe, respectively. To
evaluate the differences between human and rabbit, the tear
samples of five healthy human volunteers (22-30 yr of age)
were collected before and after excimer laser photokeratectomy
as the same method. NO production was determined from
stable end product of NO, nitrite plus nitrate concentration
using Griess reaction (18).
The rabbits were killed by a large bolus injection of intra-
venous anesthetics. The cornea was obtained and bisected under
the operating microscope. Bisected tissue sample was fixed
in 4% paraformaldehyde and embedded in paraffin for staining
with either toluidine blue for mast cell detection or, alterna-
tively, with hematoxylin-eosin staining for routine histology
and immunohistochemical study for eNOS, bNOS, iNOS
(Transduction lab, U.S.A.) and TUNEL staining using apop-
tosis detection kit (Oncor, MD, U.S.A.). Another bisected
sample embedded in O.C.T. compound (Sakura Finetek
U.S.A., Torrance, CA, U.S.A.) for detection of  -nitrotyrosine
formation was formed by powerful oxidant peroxynitrite, which
indicated NO-mediated cellular damage. 
We performed western blotting for detection of  -nitroty-
rosine in photoablated corneal tissue. Corneal tissue was
homogenized in boiling lysis buffer and centrifuged for 15
min. The supernatant was separated on 7.5% polyacrylamide
gel electrophoresis and the proteins were blotted onto poly-
vinylidene difluoride membrane. The membrane was incu-
bated with primary monoclonal anti-nitrotyrosine Ab (Upstate,
NY, U.S.A.). The specific protein was detected with anti-rab-
bit IgG (Bio-Rad, CA, U.S.A.) conjugated with the horsera-
dish peroxidase enzyme.
We also evaluated the proportion of apoptosis and necrosis
using transmission electron microscopy.
Cell culture and cell viability assay (in vitro study)
Human corneal fibroblast was prepared from the remnant
tissue of donor eyes after penetrating keratoplasty. The cells
were grown and maintained in DMEM containing 10% fetal
bovine serum, sodium bicarbonate, penicillin, and strepto-
mycin of 100 units per mL. Fibroblasts were subcultured at
80-90% confluence for passage. The third passage of fibrob-
lasts was seeded in 100 mm tissue culture dishes at a density
of 10
6 cells. Fibroblasts were washed with serum-free DMEM
medium and 2,500 cells were placed in each well in a 96-well
tissue culture plate. Cells were divided into two groups (group
I, serum-free media; group II, 10% fetal bovine serum-con-
taining media). Each group was treated with different con-
centrations of NO donor SNAP (0, 1, 5, 10, 50, 100, 500,
and 1,000  M). After 24 hr, the reduction of 3-[4,5-cime-
thylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT)
was used as an indicator of cellular toxicity. The assay was
carried out in standard fashion using the cell proliferation kit
1 (MTT assay) (19). Results were given as optical densities
(ODs) and were calculated as per cent of cell viability. 
Statistical analysis
Statistical significance was determined by analysis of variance
(ANOVA) and modified t-test to determine specific differ-
ences among groups and times.
RESULTS
Main sources of NO and peroxynitrite generation in ocu-
lar surface tissue
We found that the main sources of NO of ocular surface
tissue were corneal epithelium, fibroblasts, endothelium, and
Fig. 1. A. Normal cornea (×100). B. Immunohistochemical locali-
zation of eNOS in epithelium of peripheral cornea (arrows) (×100).
C. iNOS were strongly expressed in the corneal fibroblasts
(arrows) and also expressed weakly in the corneal epithelium
(arrow head) (×100). D. Increased iNOS expression in fibrob-
lasts (arrow heads) and inflammatory cells (arrows) (×100).
A B
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inflammatory cells, which differently expressed the isoforms
of NOS according to the inflammatory status. In normal con-
trol group, constitutive forms (eNOS and bNOS) were ex-
pressed negligible amount, revealed by immunohistochemical
staining, and iNOS was absent. In contrast, all three forms
of NOS were expressed in experimentally induced inflamma-
tion, such as photokeratectomy wound, LPS-induced uveitis
and chemically induced allergic conjunctivitis. In photoker-
atectomy wound (Group II), eNOS was strongly expressed
mainly in epithelium, and bNOS and iNOS were expressed
mainly in fibroblasts. In addition, bNOS and iNOS were local-
ized in inflammatory cells around limbal vessel 1 day after
photokeratectomy (Fig. 1).
The localization of iNOS and  -nitrotyrosine was shown
in Fig. 2A and B, depicting the staining patterns of inflam-
matory cells and limbal fibroblasts. In western blotting for
-nitrotyrosine, one labeled band (97.4 kDa), which indicat-
ed -nitrotyrosine formation of protein caused by peroxyni-
trite, was shown in photoablated cornea and this band dis-
appeared in NOS inhibitor (L-NAME)-treated group (Fig.
2C). In experimental allergic conjunctivitis, eNOS was ex-
pressed in subconjunctival vascular endothelial cells, and
bNOS and iNOS were expressed in subconjunctival mast
cells. As seen in the LPS-induced uveitis, iNOS was also ex-
pressed in many inflammatory cells and fibroblasts (data not
shown).
Critical NO concentrations and potential roles in tear
and aqueous humor
Table 1A indicates NO concentrations in normal and various
NO-related inflammatory conditions, such as photokeratec-
tomy wound, allergic conjunctivitis, and LPS-induced uveitis.
From the results of our experiment, we summarized the crit-
ical NO concentrations in Table 1B. The ratio 1.5-2.5 of nitric
oxide value, assuming the normal nitric oxide value as 1, may
play a defensive role defense, whereas much higher concen-
trations of NO (3 to 10 fold of nitric oxide value) may induce
tissue damage. 
NO-mediated toxicity in ocular surface
The corneal edema and sutural lens opacity were revealed
Fig. 2. A. The immunohistochemical localization of iNOS around the limbal vessel (V), fibroblast (arrow) and an inflammatory cell
(arrowhead) (×400). B.  -nitrotyrosine staining around the limbal vessel (V) (×400). C. Lane 1, normal cornea. Lane 2, immunoblot-
ting analysis of PTK-treated cornea reveals the overexpression of five nitrotyrosine-related proteins (arrow). Lane 3, PTK-treated
cornea applied with L-NAME. The bands are weaker than those of lane 2 and the 97.4-kDa component disappeared (arrowhead).
A B C
Fig. 3. A & B. The positive brown color for TUNEL staining cells
(arrow) (×100). Specimen at 24 hr after LPS injection (A) or NO
donor SNAP (B). C. Corneal epithelium at 24 hr after LPS injec-
tion (×4,000) ; perinuclear (NV) and cytoplasmic vacuolization.
D. Fibroblasts at 24 hr after LPS injection (×4,000); the cyto-
plasm of fibroblasts are vacuolized (CV) and the chromatin is
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in LPS-induced uveitis (Group IV), which also occurred in NO
donor-injected group (Group V). Corneal specimen showed
remarkably increased edema in LPS-induced uveitis, while
the edema was much decreased in NOS inhibitor (L-NAME)-
treated group (data not shown). This corneal edema may
indicate the loss of cellular function, which was caused by cell
death.
The NO-mediated death of these cells was revealed by
TUNEL-positive staining in corneal cells (Fig. 3A, B), which
might indicate apoptosis. In electron microscopic findings,
however, we observed that the NO-specific cell death was
represented as atypical necrosis showing intranuclear or peri-
nuclear vacuolization with nuclear compression, chromatin
condensation and mitochondrial swelling (Fig. 3C, D). Thus
the positive TUNEL staining may not be a specific finding
indicating apoptosis.
Antiapoptotic actions of NO in serum-deprived corneal
fibroblast
Since the main source of NO in corneal tissue was revealed
to be fibroblasts, we examined whether NO have influence
on apoptotic cell death of fibroblast in serum deprived con-
dition.
In in vivo system, NO-mediated cell death is mainly shown
as atypical necrosis with a few apoptosis. In contrast, in in
vitro cell culture system, apoptotic cell death was easily observed
in the condition of serum-deprivation and high dose of NO
donor, SNAP (data not shown). Serum-deprivation has also
been known to induce apoptotic cell death in other types of
fibroblast (20-22).
In serum-deprived fibroblast culture system, cell viability
was increased in a dose-dependent manner from 10  M to
500  M NO donor (SNAP), but decreased at above 1,000
M. NO did not affect the cell viability of serum-supple-
mented fibroblasts, but a higher dose (>1,000 M)  gradual-
ly decreased the cell viability (Fig. 4). 
DISCUSSION
The present study shows that NO plays different pathophy-
siologic roles in the ocular surface depending on its concen-
tration. 
In the eye, it has been suggested that NO could participate
in the pathogenesis of endotoxin induced uveitis (EIU) in rats
(23-25), a model of certain types of human uveitis (26). In
this context, we recently demonstrated that NO could be an
important factor of the inflammatory mediators of corneal
damage in streptozotocin-induced diabetic rats (27) and EIU
in rats (28, 29) and also of the induction and progress of the
allergic reaction to ocular surface (30).
NO seems to play an important role of physiological func-
tion, maintaining ocular surface cells, in tear and aqueous
humor with its higher concentration being kept in aqueous
humor than in tear, though some difference exists in each
species of animals.  Low concentrations of NO in the range
of 0.3-1  M in tear or 5-20  M in aqueous humor may be
involved in the process of wound healing after excimer laser
ablation and defense mechanisms against allergic inflamma-
Normal                             0.36±0.08
� 4.12±0.95 m*
0.31±0.09*
Photokeratectomy  wound  0.73±0.07
� 7.42±2.23 m*
0.62±0.12*
Pathologic inflammation     
Experimental allergic conjunctivitis  2.31±0.59*   Not checked
LPS-induced inflammation             3.11±0.96*    18.32±3.64*
NO donor (SNAP)                    3.71±1.84* 12.53±3.68*
* : rabbit, 
� : human.
Aqueous humor ( M) Tear ( M)
A. NO concentrations in tear and aqueous humor in normal
and various pathologic conditions
Table 1. NO concentrations and critical NO level
Concentration 1 1.5-2.5 3-10
ratio 
Function Physiologic Defense mechanism Tissue damage
Cell survival signaling Oxidative stress
Apoptosis Nitrosative  stress
DNA damage etc
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Fig. 4. Cytoprotective effects of NO donor (SNAP) on survival of
corneal fibroblast in serum-deprived condition (*, p<0.05).
Serum
Serum-free
B. Possible functional roles according to the critical NO level




*The Role of NO in Ocular Surface Cells 393
tion, whereas much higher concentrations of NO in the range
of 1.5-5  M in tear or 5-110  M in aqueous humor may
induce a significant corneal cell damage in LPS-induced uveitis
and exogenous NO donor-injected group. Since the functional
role was considered at this critical NO level in wound heal-
ing, the level of NO was implicated in the defense mechanism
of maintaining cell survival signaling to avoid harmful inflam-
matory stress. In addition, a pathological NO level might serve
as a toxicological function.
When inflammation was induced by excimer laser ablation
and LPS injection, the expression of three forms of NOS was
seen in the corneal cells, which was shown to be different
according to the environment of the inflammation. When
the amount of NO reached the maximum, the expression of
iNOS was markedly increased in fibroblasts and inflamma-
tory cells. It could be confirmed that the treatment of NOS
inhibitor decreased the amount of NO and inflammation. 
The tissue damage by NO could be confirmed by the for-
mation of  -nitrotyrosine (13, 14).  -Nitrotyrosine was mainly
expressed in inflammatory cells, especially localized in and
around the limbal vessel. The expression of iNOS in limbal
fibroblasts was likely to be related to some other functions,
such as survival of limbal stem cell. 
Because the main source of NO was fibroblast, we chose
the fibroblast culture system to determine the role of NO in
cell viability and critical NO level. We found that the NO
donor (SNAP) prevented apoptosis of corneal fibroblasts caused
by serum-deprivation in a dose-dependent manner up to 500
M SNAP, while a higher dose decreased cell viability. Thus,
these results suggested that NO-induced cytotoxicity worked
biologically on the critical NO level in vitro as well as in vivo. 
Therefore, NO may act as a double-edged sword in patho-
physiological and toxicological mechanisms of ocular surface
diseases, determined by its concentration and interaction with
other oxygen mediators depending on the degree of inflam-
mation. 
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